[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_2165 

# __Lack of novel treatment options__

## Category to which it belongs

* [The ramifications of a global crisis include disrupted education, reduced socialization, resistance to change, misinterpretation, inconsistent implementation, and increased poverty.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_132.md)

## Closest similar item

* [Lack of drug therapy options](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1139.md)
* [Lack of effective treatment](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1849.md)
* [Insufficient non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1590.md)
* [Ineffective non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1478.md)
* [Lack of treatment and resources](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2046.md)
* [Ineffective treatments based on flawed preprints](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_617.md)
* [Lack of effective pharmaceutical response](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1589.md)
* [Limited testing and treatment capabilities](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2786.md)
* [Lack of effective drugs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2684.md)
* [Lack of access to pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1151.md)

## Description of the risk

Limited availability of effective drugs for treating COVID-19.

## Is the risk affecting GBN scales

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Type of impact of the risk (according to ISO37100)

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_0.md)

## Type of purpose of the risk (according to ISO37100)

* [Well-being](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_1.md)

## Mitigations of this risk

* [Utilize ai algorithms for drug discovery and development of novel treatments.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2857.md)

## Name of the risk

Limited treatment options and increased mortality rates.

## Stakeholders who can mitigate this risk

* [Researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_124.md)

## Articles mentionning the risk

* [Digital technology and COVID-19](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_278.md)

## People affected by this risk

* [Researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [Healthcare providers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_121.md)

## Technologies linked to the risk

* [Artificial intelligence ai](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1712.md)

## Property: has_RiskType

* [Technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

